Case File №
#VI-2026-0746
Lejian Biotech Peptide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
32 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 7.1 | 7.1 | 7.1 | 25 May 2026 |
| 17a-Methyl-1-Testosterone | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| AA Water | X N/A | 1 | 4.0 | 1.0 | 1.0 | 20 Jun 2025 |
| ACE-031 | X N/A | 1 | 4.0 | 0.1 | 0.1 | 21 May 2025 |
| Alprostadil | X N/A | 1 | 4.0 | 3.0 | 3.0 | 28 Mar 2025 |
| Anavar (Oxandrolone) Raw | X N/A | 1 | 4.0 | 0.5 | 0.5 | 14 Jan 2025 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.0 | 2.2 | 2.2 | 24 Apr 2025 |
| Cerebrolysin | X N/A | 1 | 4.0 | 0.4 | 0.4 | 13 Feb 2025 |
| Chonluten | X N/A | 1 | 4.0 | 0.0 | 0.0 | 8 Jul 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Clomiphene (Clomid) Raw | X N/A | 1 | 4.0 | 0.3 | 0.3 | 17 Dec 2024 |
| Dianabol | X N/A | 1 | 4.0 | 0.3 | 0.3 | 13 Jun 2025 |
| Enclomiphene | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| EPO | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 4.0 | 0.1 | 0.1 | 13 Jun 2025 |
| Hyaluronic acid | X N/A | 1 | 4.0 | 0.0 | 0.0 | 6 May 2025 |
| Isotretinoin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| Livagen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 4.0 | 2.1 | 2.1 | 14 Jan 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 4.0 | 0.8 | 0.8 | 13 Feb 2025 |
| Pancragen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| PE 22-28 | X N/A | 1 | 4.0 | 1.5 | 1.5 | 2 Apr 2025 |
| PEG MGF | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| Phenylacetic acid CAS 103-82-2 | X N/A | 1 | 4.0 | 1.9 | 1.9 | 14 Jan 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| SR9009 | X N/A | 1 | 4.0 | 1.2 | 1.2 | 17 Dec 2024 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X N/A | 1 | 4.0 | 0.5 | 0.5 | 21 May 2025 |
| Tirzepatide 30mg Pen Kit | X N/A | 1 | 4.0 | 0.0 | 0.0 | 8 Jul 2025 |
| Vitamin B12 10mg/ml | X N/A | 1 | 4.0 | 0.0 | 0.0 | 28 Mar 2025 |
Exhibit II
Evidence Log
31 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Anavar (Oxandrolone) Raw | 4.0 C | 5g | 5.2g | +3.3% | 95.21% | 6b05kp | Lab C | Community |
| 25 May 2026 | Dianabol | 4.0 C | 100mg | 94.7mg | -5.3% | 97.89% | 1kiwcx | Lab F | Public |
| 24 May 2026 | Isotretinoin | 4.6 C | 10mg | 10.3mg | +2.6% | 99.65% | 0rgbor | Lab A | Public |
| 24 May 2026 | Livagen | 4.4 C | 5mg | 4.5mg | -9.9% | 96.93% | s2bty5 | Lab F | Public |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.0 B | 5mg | 4.4mg | -11.6% | 98.89% | wr8l90 | Lab A | Public |
| 24 May 2026 | Equipoise (Boldenone Undecylenate) | 4.0 C | 300mg/ml | 314.2mg/ml | +4.7% | 96.73% | 89g2bk | Lab D | Public |
| 24 May 2026 | Phenylacetic acid CAS 103-82-2 | 5.2 B | 100g | 111.5g | +11.5% | 97.85% | q31uzk | Lab E | Community |
| 24 May 2026 | Tirzepatide 30mg Pen Kit | 4.0 C | 2mg | 2.3mg | +12.7% | 97.87% | kjd3m9 | Lab F | Public |
| 24 May 2026 | Clomiphene (Clomid) Raw | 6.2 A | 1g | 0.9g | -7.9% | 99.92% | 0ru4f6 | Lab D | Community |
| 23 May 2026 | N-Acetyl Epitalon Amidate | 4.1 C | 10mg | 9.7mg | -3.0% | 98.47% | 9ltfhu | Lab G | Public |
| 23 May 2026 | SR9009 | 4.5 C | 20mg | 22.4mg | +12.0% | 98.21% | vs5ir5 | Lab F | Public |
| 21 May 2026 | Vitamin B12 10mg/ml | 4.0 C | 200mg/ml | 245.1mg/ml | +22.5% | 97.57% | o1s9bf | Lab C | Public |
| 19 May 2026 | Pancragen | 4.0 C | 20mg | 23.9mg | +19.7% | 96.83% | cyp7jb | Lab D | Public |
| 17 May 2026 | EPO | 4.7 C | 15mg | 12.9mg | -14.2% | 95.93% | zucikd | Lab D | Public |
| 29 Jan 2026 | AA Water | 4.0 C | 5mg | 5.2mg | +4.9% | 97.55% | u6s76j | Lab C | Public |
| 19 Jan 2026 | Hyaluronic acid | 5.8 B | 30mg | 27.9mg | -7.1% | 98.78% | jnpzpg | Lab F | Public |
| 19 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 4.8 C | 2mg | 1.8mg | -9.0% | 96.62% | 6o6dvq | Lab E | Community |
| 7 Jan 2026 | Proviron (Mesterolone) | 4.7 C | 100mg | 116.0mg | +16.0% | 97.60% | 2ia25x | Lab C | Community |
| 29 Dec 2025 | Alprostadil | 4.6 C | 50mg | 44.1mg | -11.8% | 97.35% | 30yw50 | Lab B | Public |
| 12 Dec 2025 | PE 22-28 | 4.0 C | 5mg | 4.9mg | -1.3% | 98.84% | 0h3ili | Lab B | Public |
| 12 Dec 2025 | PTD-DBM | 4.7 C | 5mg | 5.4mg | +7.3% | 99.53% | mzksjb | Lab G | Public |
| 17 Nov 2025 | ACE-031 | 4.0 C | 15mg | 14.5mg | -3.4% | 97.69% | qk12cg | Lab C | Community |
| 17 Nov 2025 | Cerebrolysin | 4.4 C | 30mg | 27.8mg | -7.3% | 97.25% | r8zaef | Lab A | Public |
| 17 Nov 2025 | PEG MGF | 4.0 C | 10mg | 12.0mg | +20.4% | 98.53% | xzr3ly | Lab C | Community |
| 14 Nov 2025 | 17a-Methyl-1-Testosterone | 4.0 C | 100mg | 99.4mg | -0.6% | 95.31% | a220ed | Lab B | Community |
| 14 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 5.5 B | 10mg | 10.5mg | +5.4% | 97.19% | 3iaup6 | Lab B | Community |
| 4 Nov 2025 | Enclomiphene | 4.0 C | 25mg | 29.3mg | +17.4% | 96.85% | ajubm6 | Lab E | Public |
| 4 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.0 C | 20mg | 18.1mg | -9.6% | 98.17% | gurpom | Lab F | Community |
| 9 Oct 2025 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 4.0 C | 1g | 1.1g | +7.0% | 97.66% | 6zwlz7 | Lab A | Public |
| 9 Oct 2025 | Chonluten | 4.5 C | 30mg | 32.4mg | +8.0% | 95.54% | zx8t8a | Lab G | Public |
| 9 Oct 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.0 C | 5mg | 5.3mg | +6.9% | 99.51% | op0uoz | Lab D | Public |
— END OF EVIDENCE LOG —